IL-17A Response Independent of CRP in Ankylosing Spondylitis
(MedPage Today) -- Secukinumab effective even with normal levels of inflammatory marker
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Ankylosing Spondylitis | Primary Care